GlassScriptPhysician profile
Anthony Errico
NPI 1659834604
$43,791.37
in general payments reported to CMS, 2019-2025
10 companies · $475 in 2025
The $475 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $166 · 2020: $975 · 2021: $244 · 2022: $184 · 2023: $18K · 2024: $24K · 2025: $475.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $24K · Consulting Fee: $13K · Travel and Lodging: $4,286 · Food and Beverage: $1,599.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $23,756.05 |
| Consulting Fee | $12,581.25 |
| Travel and Lodging | $4,286.46 |
| Food and Beverage | $1,598.82 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sanara Medtech INC. | $36,280.35 | 2021-2025 | Celleraterx, Biasurge, Celleraterx |
| Musculoskeletal Transplant Foundation INC. | $5,832.64 | 2022-2024 | |
| Liberty Surgical INC. | $959.57 | 2020 | |
| Smith+Nephew, INC. | $195.46 | 2021-2023 | Panta 2, Integraendoscopic Gastro Release System |
| Organogenesis INC. | $173.62 | 2024 | |
| Integra Lifesciences Corporation | $141.95 | 2019 | |
| Stryker Corporation | $116.25 | 2024-2025 | Allofiber, Prostep Mica, Viaflow |
| Depuy Synthes Sales INC. | $39.30 | 2021 | |
| Zimmer Biomet Holdings, INC. | $39.01 | 2019-2020 | |
| Amgen INC. | $13.22 | 2024 | Krystexxa |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Errico listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.